Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Size & Outlook

The high potency active pharmaceutical ingredients market in Middle East & Africa is expected to reach a projected revenue of US$ 1,123.5 million by 2030. A compound annual growth rate of 6.7% is expected of Middle East & Africa high potency active pharmaceutical ingredients market from 2024 to 2030.
Revenue, 2023 (US$M)
$715.4
Forecast, 2030 (US$M)
$1,123.5
CAGR, 2024 - 2030
6.7%
Report Coverage
Middle East & Africa

Middle East & Africa high potency active pharmaceutical ingredients market, 2018-2030 (US$M)

Middle

Related Markets

MEA high potency active pharmaceutical ingredients market highlights

  • The MEA high potency active pharmaceutical ingredients market generated a revenue of USD 715.4 million in 2023.
  • The market is expected to grow at a CAGR of 6.7% from 2024 to 2030.
  • In terms of segment, synthetic was the largest revenue generating product in 2023.
  • Biotech is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 715.4 million
Market revenue in 2030USD 1,123.5 million
Growth rate6.7% (CAGR from 2023 to 2030)
Largest segmentSynthetic
Fastest growing segmentBiotech
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSynthetic, Biotech
Key market players worldwideBasf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.7% of the global high potency active pharmaceutical ingredients market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 11,684.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

High Potency Active Pharmaceutical Ingredients Market Companies

Name Profile # Employees HQ Website

Middle East & Africa high potency active pharmaceutical ingredients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 73.4% in 2023. Horizon Databook has segmented the Middle East & Africa high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.


Rising economic development coupled with high unmet healthcare needs is fueling the growth of Middle East and Africa high potency active pharmaceutical ingredients market. This region includes South Africa and Saudi Arabia.

According to WHO, noncommunicable diseases and injuries account for 48% of the deaths in South Africa. The rate of diagnosis of cancer is low in the region. The delay in treatment and diagnosis leads to low survival rates. This creates an unmet need for low priced and economical tests in the region, which is expected to fuel the market growth.

Furthermore, Saudi Arabia reports 24,485 new cancer cases annually. According to JTO in 2019, lung cancer rate is growing in the region, which can be attributed to the fact that 46% of the population smokes daily. Various initiatives have been undertaken by the government to reduce the incidence of these diseases.

Reasons to subscribe to Middle East & Africa high potency active pharmaceutical ingredients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa high potency active pharmaceutical ingredients market databook

  • Our clientele includes a mix of high potency active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa high potency active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA high potency active pharmaceutical ingredients market size, by country, 2018-2030 (US$M)

Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)

MEA high potency active pharmaceutical ingredients market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more